DiBiase Mary - Insider Non-Derivative Transactions at X4 Pharmaceuticals, Inc (XFOR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 9, 2024, DiBiase Mary's relationship to X4 Pharmaceuticals, Inc (XFOR) is Officer (Chief Operating Officer), and currently has 289,110 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XFOR insiders.
Data Source: SEC.
DiBiase Mary - Insider Non-Derivative Transactions of XFOR Common Stock
DiBiase Mary - Insider Non-Derivative Transactions at XFOR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 10, 2024 | Sell -- (Common Stock) | 2642 | 0.66 | 289110 |
| Mar 12, 2024 | Sell -- (Common Stock) | 15409 | 0.88 | 291752 |
| Feb 13, 2024 | Sell -- (Common Stock) | 3683 | 1.01 | 307161 |
| Nov 2, 2023 | Sell -- (Common Stock) | 67695 | 0.73 | 310844 |
| Nov 1, 2023 | Acquisition -- (Common Stock) | 230645 | 0 | 378539 |
| Sep 9, 2023 | Sell -- (Common Stock) | 2642 | 1.25 | 147894 |
| Jul 1, 2023 | Sell -- (Common Stock) | 464 | 1.89 | 150536 |
| Jun 24, 2023 | Sell -- (Common Stock) | 857 | 1.93 | 151000 |
| Jun 16, 2023 | Sell -- (Common Stock) | 857 | 2.23 | 151857 |
| Mar 11, 2023 | Sell -- (Common Stock) | 18192 | 0.84 | 152714 |
| Feb 14, 2023 | Sell -- (Common Stock) | 4348 | 0.93 | 170906 |